• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.01%

    More On TLB.TO



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    TearLab Corporation (TLB.TO)

    3.06 0.00(0.00%) Jul 28, 11:30AM EDT
    Add to Portfolio
    ProfileGet Profile for:
    TearLab Corporation
    9980 Huennekens Street
    Suite 100
    San Diego, CA 92121
    United States - Map
    Phone: 858-455-6006
    Fax: 858-812-0540
    Website: http://www.tearlab.com

    Index Membership:N/A
    Industry:Medical Laboratories & Research
    Full Time Employees:132

    Business Summary 

    TearLab Corp. operates as an ophthalmic device company in the United States. It develops and markets lab-on-a-chip technologies that enable eye care practitioners to enhance standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The company’s TearLab Osmolarity System is a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The company’s system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corp. was founded in 1996 and is headquartered in San Diego, California.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on TearLab Corporation

    Key Executives 
    Mr. Elias Vamvakas , 56
    Chairman, Chief Exec. Officer and Sec.
    Mr. Joseph Jensen , 43
    Pres and Chief Operating Officer
    Mr. Paul Smith , 37
    VP of International Markets
    Dr. Venkiteshwar S. Manoj Ph.D., 37
    VP of Medical Affairs
    Dr. Richard L. Lindstrom M.D., 67
    Scientific Advisor, Director and Chairman of Compensation Committee
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in CAD.